- Home
- MX vs ABOS Comparison
MX vs ABOS Comparison
Compare MX & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MX
- ABOS
- Stock Information
- Founded
- MX 2003
- ABOS 1996
- Country
- MX South Korea
- ABOS United States
- Employees
- MX N/A
- ABOS N/A
- Industry
- MX Semiconductors
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- MX Technology
- ABOS Health Care
- Exchange
- MX Nasdaq
- ABOS Nasdaq
- Market Cap
- MX 103.8M
- ABOS 84.2M
- IPO Year
- MX N/A
- ABOS 2021
- Fundamental
- Price
- MX $3.02
- ABOS $1.44
- Analyst Decision
- MX Strong Buy
- ABOS Strong Buy
- Analyst Count
- MX 2
- ABOS 3
- Target Price
- MX $5.75
- ABOS $8.00
- AVG Volume (30 Days)
- MX 347.6K
- ABOS 211.5K
- Earning Date
- MX 10-29-2025
- ABOS 08-12-2025
- Dividend Yield
- MX N/A
- ABOS N/A
- EPS Growth
- MX N/A
- ABOS N/A
- EPS
- MX N/A
- ABOS N/A
- Revenue
- MX $234,243,000.00
- ABOS N/A
- Revenue This Year
- MX N/A
- ABOS N/A
- Revenue Next Year
- MX $7.05
- ABOS N/A
- P/E Ratio
- MX N/A
- ABOS N/A
- Revenue Growth
- MX 16.02
- ABOS N/A
- 52 Week Low
- MX $2.51
- ABOS $0.86
- 52 Week High
- MX $5.16
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- MX 45.88
- ABOS 53.39
- Support Level
- MX $2.89
- ABOS $1.34
- Resistance Level
- MX $3.05
- ABOS $1.47
- Average True Range (ATR)
- MX 0.11
- ABOS 0.08
- MACD
- MX 0.05
- ABOS 0.00
- Stochastic Oscillator
- MX 56.25
- ABOS 46.67
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.